BIS:NSD-ProShares UltraShort Nasdaq Biotechnology (USD)

ETF | Trading--Inverse Equity | NSD

Last Closing Price

USD 20.90

Change

0.00 (0.00)%

Market Cap

USD 9.72M

Volume

2.30K

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict


BIS Stock Forecast & Price:
Based on the ProShares UltraShort Nasdaq Biotechnology stock forecasts from 0 analysts, the average analyst target price for ProShares UltraShort Nasdaq Biotechnology is not available over the next 12 months. ProShares UltraShort Nasdaq Biotechnology’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of ProShares UltraShort Nasdaq Biotechnology is Neutral, which is based on 3 positive signals and 3 negative signals. At the last closing, ProShares UltraShort Nasdaq Biotechnology’s stock price was USD 20.90. ProShares UltraShort Nasdaq Biotechnology’s stock price has changed by -2.29% over the past week, -15.83% over the past month and +21.37% over the last year.

No recent analyst target price found for ProShares UltraShort Nasdaq Biotechnology
No recent average analyst rating found for ProShares UltraShort Nasdaq Biotechnology

About ProShares UltraShort Nasdaq Biotechnology (BIS:NSD)

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol ProShares UltraShort Nasdaq Biotechnology Allocation
AMGN 8.14 %
GILD 7.41 %
VRTX 7.21 %
BIIB 6.12 %
ILMN 5.67 %
REGN 4.13 %
ALXN 3.02 %
SGEN 2.25 %
INCY 2.09 %
BMRN 1.91 %
Top Sectors

N/A

Top Regions

N/A

Valuation Growth & Performance

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-08-14 )

Largest Industry Peers for Trading--Inverse Equity

Symbol Name Mer Price(Change) Market Cap
SQQQ ProShares UltraPro Short QQQ 0.95 %

N/A

USD4.23B
ZBIO ProShares UltraPro Short Nasda.. 0.95 %

N/A

USD2.51M

ETFs Containing BIS

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Trading--Inverse Equity)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.14% 50% F 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.14% 50% F 86% B
Trailing 12 Months  
Capital Gain 21.37% 100% A+ 93% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.37% 100% A+ 92% A-
Trailing 5 Years  
Capital Gain -78.37% 100% A+ 10% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -78.37% 100% A+ 10% F
Average Annual (5 Year Horizon)  
Capital Gain -21.45% 100% A+ 11% F
Dividend Return 0.50% 50% F 15% F
Total Return -20.96% 100% A+ 11% F
Risk Return Profile  
Volatility (Standard Deviation) 30.86% 50% F 53% F
Risk Adjusted Return -67.90% 100% A+ 9% F
Market Capitalization 9.72M 50% F 2% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.